Shareholders meeting

Date: July 02, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Sub.: Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015- Notice of Postal Ballot Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), as amended from time to time, please find attached herewith a copy of the Postal Ballot Notice, dated June 29, 2026, along with the Explanatory Statement (“Postal Ballot Notice”), dispatched today, for seeking the approval of the Members of Senores Pharmaceuticals Limited (“the Company”) on items of Special Business as mentioned in the said Notice: Sr. Description of Resolution Type of Resolution 1. To consider and approve Material Related Party transactions with Havix Ordinary Resolution Group INC. d/b/a Aavis Pharmaceuticals 2. To consider and approve Material Related Party transactions with Ordinary Resolution Ratnatris Pharmaceuticals Private Limited 3. To consider and approve Material Related Party transactions with Apnar Ordinary Resolution Pharma Private Limited 4. To consider and approve Material Related Party transactions between Ordinary Resolution the fellow subsidiaries of the Company viz. Havix Group INC. d/b/a Aavis Pharmaceuticals and Senores Pharmaceuticals INC. 5. To consider and approve Material Related Party transactions between Ordinary Resolution the fellow subsidiaries of the Company viz. Havix Group INC. d/b/a Aavis Pharmaceuticals and Apnar Pharma Private Limited 6. To consider and approve Enhancement of Existing Limit to advance any Special Resolution Loan/Give Guarantee/Provide Security under Section 185 of the Companies Act, 2013 7. To consider and approve Enhancement of the Existing Limit under Special Resolution Section 186 of the Companies Act, 2013 8. Variation in the objects / terms of utilisation of the Initial Public Offering Special Resolution (“IPO”) proceeds and extension of time limit for utilisation of the IPO Proceeds Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 The schedule of events for the Postal Ballot is as given under: Cut-off date (for dispatch and e-voting) Tuesday, June 30, 2026 Completion date of sending of Postal Ballot Notice through Thursday, July 02, 2026 e-mail E-voting start date/time Sunday, July 05, 2026 (09:00 A.M. IST) E-voting end date/time Monday, August 03, 2026 (05:00 P.M. IST) Voting Results along with Scrutinizer’s On or before Wednesday, August 05, 2026 Report The Postal Ballot Notice along with e-voting instructions has been made available on the website of the Company at www.senorespharma.com. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Deval Rajnikant Shah Whole Time Director & CFO DIN: 00332722 Enclosure: As Above Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 SENORES PHARMACEUTICALS LIMITED Regd. Office: 1101 to 1103, 11th Floor, South Tower, One 42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad, Gujarat – 380054 Tel: 079-2999 9857 | CIN: L24290GJ2017PLC100263 Website: www.senorespharma.com | Email ID: cs@senorespharma.com NOTICE OF POSTAL BALLOT Pursuant to Sections 108 and 110 of the Companies Act, 2013 read with Rules 20 and 22 of the Companies (Management and Administration) Rules, 2014 Dear Member(s), NOTICE is hereby given to the members of Senores Pharmaceuticals Limited (the “Company”) pursuant to the provisions of Sections 108, 110 and all other applicable provisions of the Companies Act, 2013 (“Act”) read with the Companies (Management and Administration) Rules, 2014, (“Rules”), which shall include any statutory modifications, amendments or re-enactments thereto) read with General Circular Nos. 14/2020 dated April 08, 2020, 17/2020 dated April 13, 2020, 22/2020 dated June 15, 2020, 33/2020 dated September 28, 2020, 39/2020 dated December 31, 2020, 10/2021 dated June 23, 2021, 20/2021 dated December 08, 2021, 3/2022 dated May 05, 2022, 11/2022 dated December 28, 2022 , 09/2023 dated September 25, 2023, 09/2024 dated September 19, 2024 and 03/2025 dated September 23, 2025 issued by the Ministry of Corporate Affairs, Government of India (the “MCA Circulars”), Secretarial Standard-2 on General Meetings (“SS-2”) issued by the Institute of Company Secretaries of India (as amended from time to time), Regulation 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “Listing Regulations”), and subject to other applicable rules, regulations, and guidelines of Securities and Exchange Board of India (“SEBI”), and/or National Stock Exchange of India Limited (“NSE”) and BSE Limited (“BSE”) (NSE and BSE collectively referred to as “Stock Exchanges”), where the equity shares of the company are listed and other applicable law, rules and regulations (including any statutory modification(s) or re-enactment(s) thereof, for the time being in force), read with the equity listing agreement executed with the stock exchange on which the equity shares of the Company are listed, for seeking approval of the shareholders for matters as considered in the Resolution(s) appended below through Postal Ballot (“Postal Ballot”) by way of e-voting only. Pursuant to Sections 102, 110 and other applicable provisions of the Act, the Explanatory Statement pertaining to the said Resolution setting out the material facts and related particulars is annexed hereto. This Postal Ballot Notice is being sent in electronic form to those Members, whose names appear in the Register of Members/List of Beneficial Owners as on Tuesday, June 30, 2026 (“Record Date”) as received from MUFG Intime India Private Limited (formerly known as Link Intime India Private Limited), the Registrar and Share Transfer Agent (“MUFG Intime” or “RTA”) of the Company and whose e-mail addresses are registered with the Depositories. In compliance with the provisions of Section 108 and Section 110 of the Act read with Rule 20 and 22 of the Rules, Regulation 44 of the Listing Regulations, and SS-2, the Company is pleased to provide e-voting facility to its Members, to enable them to cast their votes electronically. The detailed procedure with respect to e-voting is mentioned in this Notice. The Company has engaged the services of MUFG Intime for facilitating e-voting. The Company has made necessary Page 1 of 47 arrangements with RTA to enable the Members to register their e-mail address. Those Members who have not yet registered their e-mail address are requested to register the same by following the procedure set out in this Postal Ballot Notice. The Board has appointed Mr. Mukesh Shah, Practicing Company Secretary, (CP No. 2213/Membership No.: FCS5827) as the Scrutinizer (“Scrutinizer”) to scrutinize and ensure that the Postal Ballot / e-voting process are conducted in a fair and transparent manner. Members desiring to exercise their vote through the e-voting process are requested to carefully read the instructions indicated in this Notice and record their assent (FOR) or dissent (AGAINST) by following the procedure as stated in the Notes forming part of the Notice. The votes can be cast during the following voting period [Showing first 8,000 characters — download PDF for full document]